Director, Global Program Lead, External Innovation & Due Diligence

<div class="content-intro"><p></p> <div data-ogsc="black"><span data-ogsc="" data-ogsb="yellow"><strong data-ogsc="" data-olk-copy-source="MessageBody">About Acadia Pharmaceuticals</strong></span></div> <div data-ogsc="black"> </div> <div data-ogsc="black"><span data-ogsc="" data-ogsb="yellow">Acadia is committed to turning scientific promise into meaningful innovation that makes the difference for underserved neurological and rare disease communities around the world. Our commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome. We are developing the next wave of therapeutic advancements with a robust and diverse pipeline that includes mid- to late-stage programs in Alzheimer’s disease psychosis and Lewy body dementia psychosis, along with earlier-stage programs that address other underserved patient needs. At Acadia, we’re here to be their difference.</span></div></div><p><strong><u><span data-contrast="auto">Please note that this position can be based in San Diego, CA, San Francisco, CA OR Princeton, NJ. </span> <span data-contrast="auto">Acadia's hybrid model requires this role to work in our office three days per week on average.</span></u></strong></p> <p><strong><u>Position Summary:</u></strong><u> </u></p> <p>The Director, External Innovation will serve as the R&D project/program lead for external opportunity due diligence, with a particular focus on clinical-stage assets and drug development programs. The role will lead cross-functional clinical, scientific, and strategic evaluation of opportunities aligned with Acadia’s corporate strategy and R&D portfolio across neuroscience, psychiatry, neuro-rare, and rare disease.</p> <p>The Director will support the development of preliminary integrated development scenarios, resource assumptions, and value drivers to inform opportunity evaluation, investment decisions, and governance discussions. As a strategic integrator across Business Development, Clinical and Nonclinical Development, Regulatory, CMC, Commercial, Finance, Legal, and other functions, the Director will synthesize complex scientific, clinical, competitive, and financial information into clear recommendations and executive-ready decision materials to support external asset evaluation, due diligence, and potential transaction execution.</p> <p><strong><u>Primary Responsibilities:</u></strong></p> <ul> <li>Serve as the R&D project lead for external opportunity due diligence, coordinating cross-functional input from Clinical and Nonclinical Development, Regulatory, CMC, Commercial, Finance, Legal, and other key stakeholders</li> <li>Lead or co-lead the development of diligence workplans, including key questions, timelines, risk assessments, decision frameworks, and preliminary integrated development scenarios, resource assumptions, and value drivers to inform investment decisions</li> <li>Build preliminary integrated development scenarios, resource assumptions, and value drivers to inform diligence and investment decisions</li> <li>Contribute to the development of integrated opportunity assessments that evaluate scientific rationale, clinical development strategy, unmet need, competitive differentiation, regulatory considerations, development risk, commercial potential, and strategic fit</li> <li>Apply clinical development and asset leadership expertise to identify key diligence questions, development risks, opportunities, and assumptions associated with external assets</li> <li>Translate complex scientific, clinical, competitive, and financial information into clear recom